A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL) (LOTIS-9)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05144009 |
Recruitment Status :
Completed
First Posted : December 3, 2021
Last Update Posted : January 31, 2024
|
Sponsor:
ADC Therapeutics S.A.
Information provided by (Responsible Party):
ADC Therapeutics S.A.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | January 22, 2024 |
Actual Study Completion Date : | January 22, 2024 |